Mutual Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$912K Buy
10,701
+308
+3% +$27.5K 0.02% 635
2025
Q4
$821K Buy
10,393
+254
+3% +$19.9K 0.02% 659
2025
Q3
$795K Buy
10,139
+1,874
+23% +$160K 0.02% 662
2025
Q2
$727K Buy
8,265
+401
+5% +$36.6K 0.02% 629
2025
Q1
$739K Sell
7,864
-556
-7% -$49.8K 0.02% 559
2024
Q4
$746K Sell
8,420
-6,947
-45% -$663K 0.02% 572
2024
Q3
$1.53M Buy
15,367
+9,238
+151% +$942K 0.04% 341
2024
Q2
$618K Buy
6,129
+374
+6% +$34.5K 0.02% 632
2024
Q1
$518K Buy
5,755
+318
+6% +$26.9K 0.02% 686
2023
Q4
$433K Buy
5,437
+421
+8% +$31.7K 0.02% 697
2023
Q3
$357K Sell
5,016
-11,464
-70% -$857K 0.01% 720
2023
Q2
$1.27M Buy
16,480
+82
+0.5% +$6.35K 0.05% 366
2023
Q1
$1.23M Buy
16,398
+13,726
+514% +$1.02M 0.05% 366
2022
Q4
$211K Buy
+2,672
New +$200K 0.01% 859

Other funds holding CL

Mutual Advisors's CL Position: Q1 2026 in Review

Mutual Advisors increased its Colgate-Palmolive (CL) stake by 3% in Q1 2026, buying an estimated $27.5K and bringing the position to 10,701 shares worth $912K. The position accounts for 0.02% of the portfolio, ranked #635.

Mutual Advisors first reported a position in CL in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.53M in Q3 2024. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Mutual Advisors held 10,701 shares of Colgate-Palmolive worth $912K as of Q1 2026.
  • Mutual Advisors bought 308 Colgate-Palmolive shares in Q1 2026, an estimated $27.5K.
  • Colgate-Palmolive made up 0.02% of Mutual Advisors's portfolio in Q1 2026, its #635 holding.
  • Mutual Advisors first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 14 quarters since.
  • Mutual Advisors's Colgate-Palmolive position peaked at $1.53M in Q3 2024.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.